Literature DB >> 22974520

Negative symptom measurement in individuals at-risk for psychosis.

Andrea L Pelletier, Vijay A Mittal.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22974520      PMCID： PMC3890233          DOI： 10.1016/j.psychres.2012.08.020

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN： 0165-1781            Impact factor:   3.222


× No keyword cloud information.
  9 in total

1.  The brief negative symptom scale: psychometric properties.

Authors:  Brian Kirkpatrick; Gregory P Strauss; Linh Nguyen; Bernard A Fischer; David G Daniel; Angel Cienfuegos; Stephen R Marder
Journal:  Schizophr Bull       Date:  2010-06-17       Impact factor: 9.306

2.  [Dementia praecox or the group of schizophrenias].

Authors:  Eugen Bleuler
Journal:  Vertex       Date:  2010 Sep-Oct

3.  The NIMH-MATRICS consensus statement on negative symptoms.

Authors:  Brian Kirkpatrick; Wayne S Fenton; William T Carpenter; Stephen R Marder
Journal:  Schizophr Bull       Date:  2006-02-15       Impact factor: 9.306

4.  The initial prodrome in psychosis: descriptive and qualitative aspects.

Authors:  A R Yung; P D McGorry
Journal:  Aust N Z J Psychiatry       Date:  1996-10       Impact factor: 5.744

5.  Negative symptoms in individuals at clinical high risk of psychosis.

Authors:  Danijela Piskulic; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Robert Heinssen; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Thomas H McGlashan
Journal:  Psychiatry Res       Date:  2012-03-22       Impact factor: 3.222

6.  Toward the next generation of negative symptom assessments: the collaboration to advance negative symptom assessment in schizophrenia.

Authors:  Jack J Blanchard; Ann M Kring; William P Horan; Raquel Gur
Journal:  Schizophr Bull       Date:  2010-09-22       Impact factor: 9.306

7.  Development and psychometric validation of the Clinical Assessment Interview for Negative Symptoms (CAINS).

Authors:  William P Horan; Ann M Kring; Raquel E Gur; Steven P Reise; Jack J Blanchard
Journal:  Schizophr Res       Date:  2011-07-27       Impact factor: 4.939

8.  Diagnosing schizophrenia in the initial prodromal phase.

Authors:  J Klosterkötter; M Hellmich; E M Steinmeyer; F Schultze-Lutter
Journal:  Arch Gen Psychiatry       Date:  2001-02

9.  Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia.

Authors:  Barbara A Cornblatt; Andrea M Auther; Tara Niendam; Christopher W Smith; Jamie Zinberg; Carrie E Bearden; Tyrone D Cannon
Journal:  Schizophr Bull       Date:  2007-04-17       Impact factor: 9.306
  9 in total
  7 in total

1.  Self-Evaluation of Negative Symptoms: A Novel Tool to Assess Negative Symptoms.

Authors:  Sonia Dollfus; Cyril Mach; Rémy Morello
Journal:  Schizophr Bull       Date:  2015-11-12       Impact factor: 9.306

2.  Neurological soft signs predict abnormal cerebellar-thalamic tract development and negative symptoms in adolescents at high risk for psychosis: a longitudinal perspective.

Authors:  Vijay A Mittal; Derek J Dean; Jessica A Bernard; Joseph M Orr; Andrea Pelletier-Baldelli; Emily E Carol; Tina Gupta; Jessica Turner; Daniel R Leopold; Briana L Robustelli; Zachary B Millman
Journal:  Schizophr Bull       Date:  2013-12-27       Impact factor: 9.306

3.  Increased postural sway predicts negative symptom progression in youth at ultrahigh risk for psychosis.

Authors:  Derek J Dean; Jerillyn S Kent; Jessica A Bernard; Joseph M Orr; Tina Gupta; Andrea Pelletier-Baldelli; Emily E Carol; Vijay A Mittal
Journal:  Schizophr Res       Date:  2015-01-16       Impact factor: 4.939

4.  Physical activity level and medial temporal health in youth at ultra high-risk for psychosis.

Authors:  Vijay A Mittal; Tina Gupta; Joseph M Orr; Andrea Pelletier-Baldelli; Derek J Dean; Jessica R Lunsford-Avery; Ashley K Smith; Briana L Robustelli; Daniel R Leopold; Zachary B Millman
Journal:  J Abnorm Psychol       Date:  2013-11

5.  Orbitofrontal cortex volume and intrinsic religiosity in non-clinical psychosis.

Authors:  Andrea Pelletier-Baldelli; Derek J Dean; Jessica R Lunsford-Avery; Ashley K Smith Watts; Joseph M Orr; Tina Gupta; Zachary B Millman; Vijay A Mittal
Journal:  Psychiatry Res       Date:  2014-04-04       Impact factor: 3.222

6.  Duration of attenuated positive and negative symptoms in individuals at clinical high risk: Associations with risk of conversion to psychosis and functional outcome.

Authors:  Ricardo E Carrión; Docia Demmin; Andrea M Auther; Danielle McLaughlin; Ruth Olsen; Todd Lencz; Christoph U Correll; Barbara A Cornblatt
Journal:  J Psychiatr Res       Date:  2016-06-26       Impact factor: 4.791

7.  Correspondence between psychometric and clinical high risk for psychosis in an undergraduate population.

Authors:  David C Cicero; Elizabeth A Martin; Theresa M Becker; Anna R Docherty; John G Kerns
Journal:  Psychol Assess       Date:  2014-04-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.